1:58 PM
 | 
Jan 02, 2018
 |  BC Innovations  |  Distillery Techniques

Biomarkers; Other

TECHNOLOGY: Tissue markers; computational models

An algorithm based on three measures of tumor neoantigens could help predict survival in pancreatic cancer patients. The algorithm calculates a cumulative “quality score” for the neoantigens in a tumor using the ratio of the binding affinity of the patient’s human leukocyte antigen (HLA)...

Read the full 220 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$18 USD
More Info >